P reoperative evaluation is a fundamental component of anesthetic delivery because it guides anesthetic management and postoperative care. This is especially true in the ambulatory surgical setting where preoperative evaluation also informs patient selection. Patient selection, in turn, is the cornerstone for safe and efficient ambulatory anesthesia care.
In the outpatient setting, the preoperative anesthesia assessment-which exists in a variety of forms-is a key tool for optimizing both medical and administrative outcomes. Proactive identification and management of medical problems avoids last-minute surprises that at best interrupt patient flow in an ambulatory surgery center and at worst contribute to adverse medical outcomes. This chapter will review: (1) the basic requirements for preoperative evaluation as determined by payers and regulators; (2) models of preoperative evaluation and their merits; and (3) preanesthetic evaluation of selected comorbidities that are particularly relevant to the outpatient setting, such as obesity, sleep apnea, cardiac disease, and insulin-requiring diabetes.
Proactive identification and management of medical problems avoids last-minute surprises that at best interrupt patient flow in an ambulatory surgery center and at worst contribute to adverse medical outcomes.
GROUND RULES
The ground rules that govern United States hospitals as set forth by the Joint Commission state that a patient undergoes a medical history and physical examination no more than 30 days before any operative or high-risk procedure (Standard: RC.02.01.03, PC.01.02.03, EP 5). The American Society of Anesthesiologists (ASA) has adopted standards (last amended in 2005) for preanesthesia care that are more specific (Table 1 , www.asahq.org/publications AndServices/standards/03.pdf, accessed May 2010).
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Furthermore, the ASA Statement on Documentation (last amended in 2008) lists specific elements of the preanesthesia evaluation that should be recorded and also states that this is the responsibility of an anesthesiologist (www.asahq.org/publicationsAndServices/sgstoc.htm, accessed May 2010). The content of this evaluation is to include medical history, anesthetic history, medications, appropriate physical examination including vital signs and documentation of airway assessment, review of objective diagnostic data and medical records, medical consultations when applicable, assignment of ASA physical status, formulation of anesthetic plan, and documentation of risks and benefits of the plan ''including discharge issues when indicated'' (see Supplemental Digital Content 1, http://links.lww.com/ASA/A53). The Center for Medicare and Medicaid Services issued ''Revised Hospital Anesthesia Services Interpretive Guidelines'' in December 2009 that reflect the ASA Statement for documenting preoperative assessment (see Supplemental Digital Content 2, http://links.lww.com/ASA/A54).
What, then, is the best approach for satisfying these minimum requirements and professional society expectations? Clearly, the answer depends on the type of facility, patient population, and procedures. Patient selection criteria, and hence evaluation paradigms, for a free-standing or office-based practice will undoubtedly differ from a hospital-based practice in a tertiary care center. Despite these differences, there are some unifying guiding principles that apply to all settings.
For starters, the basic requirements as outlined above need to be satisfied in a manner that is consistent and efficient. The goal is to determine who is fit for outpatient surgery and then to optimize those candidates. The extent and focus of the preanesthesia assessment is determined by the patient's comorbidities and type of surgical procedure.
Second, a plethora of studies indicate that laboratory examinations should be obtained for medical indications only and that ''routine'' testing is of no value, especially in the ambulatory setting.
1-3 However, the information gained from a thorough history and physical examination and clear communication with members of the perioperative team is of considerable benefit. Investigators of the Australian Incident Monitoring Study database identified poor airway assessment, communication problems, and inadequate preoperative evaluation as contributing factors in 197 preventable major adverse events (incidence 3.1%) including death and major morbidity. 4 Although laboratory examinations may not be useful, basic patient evaluation and communication of salient features are still essential.
MODELS FOR SYSTEMATIC PREOPERATIVE EVALUATION
Over the past few decades, several models have been developed to facilitate preoperative communication, triaging, and medical evaluation. All of these models have their strengths and weaknesses, depending on the facility (free-standing center, office, hospital, etc.) and the patient population.
Patients can be evaluated on the day of surgery or seen in a preoperative evaluation clinic, or some hybrid version. The preferred model depends on patient demographics and type of facility. Patients evaluated on the day of surgery have usually had a screening telephone interview with a preoperative nurse several days in advance of the procedure with anesthesiologist consultation obtained, as necessary. This method can be quite effective and efficient if relevant patient records (ie, history and physical examination, laboratory values) are available at the time of the telephone screen, the nurses are well trained at interviewing, and algorithms for seeking physician consultation exist. At the other end of the spectrum are preoperative evaluation clinics where patients are seen well in advance of surgery by an anesthesiologist and/or advanced practice nurse. These clinics are usually found in larger tertiary medical centers and face-to-face visits are reserved for patients with extensive comorbidities. These clinics require institutional support and delineated organizational infrastructure. 5 Regardless of the method used, preoperative screening is cost effective and has the potential to yield substantial dividends by minimizing delays, cancellations, and opportunity costs.
Regardless of the method used, preoperative screening is cost effective and has the potential to yield substantial dividends by minimizing delays, cancellations, and opportunity costs. [6] [7] [8] Although data for ambulatory surgery are limited, in a large urban medical center, Ferschl et al. 7 found that same day surgery patients seen in the preoperative evaluation clinic had a cancellation rate of 8.4% Data are beginning to emerge using preoperative assessment to predict future hospital costs. In the National Surgical Quality Improvement Program, 51 preoperative risk factors such as serum creatinine 4 1.2 or previous cardiac surgery predicted postoperative cost variation resulting from complications and extended hospital stay. 9 The authors speculate that preoperative optimization of these risk factors would mitigate the occurrence of postoperative complications and hospital costs. This remains to be determined.
Whether telephone screens or preoperative clinic visits are used, the model chosen for ambulatory anesthesia evaluation needs to emphasize patient selection using evidence-based algorithms developed by anesthesiologists and broadly shared with surgeons and their offices. This will permit effective triaging of patients and optimization of medical conditions preoperatively. For example, a patient with a drug-eluting cardiac stent placed within the year who abruptly discontinued clopidigrel would not be an appropriate candidate for elective surgery, regardless of the venue. However, the same patient a year later may be perfectly appropriate for a hospital-based surgery center but not an office setting, depending on the procedure and other comorbidities.
MEDICAL EVALUATION
This discussion will encompass medical comorbidities that have considerable relevance to the outpatient setting resulting from the associated perioperative risks and dilemmas posed by discharging the patient within a few hours of surgery and anesthesia. Areas of focus include cardiac disease with an emphasis on stents and implantable cardiac rhythm devices (CRDs), obesity and obstructive sleep apnea (OSA), and diabetes and perioperative glycemic control.
CARDIAC
There is an abundance of data, guidelines, and opinions to guide preoperative evaluation of cardiac risk. This section will focus on key studies and guidelines that are applicable to outpatients because the type of surgery is usually limited in scope, with minimal fluid shifts. However, most studies that form the backbone of current guidelines were extrapolated from patients having extensive procedures.
In guideline parlance, outpatient procedures are generally considered ''low risk''; however, lumping these procedures can be misleading (ie, a cataract repair is not equivalent to a rigid bronchoscopy). Consequently, it becomes incumbent on the anesthesiologist to sort out which patients are at risk and require more extensive evaluation. Risk stratification methods are useful, however, they all have their limitations; namely, they are often derived from observational studies at a single institution. Nevertheless, common themes emerge.
A landmark study of 4,315 patients over 50 years having noncardiac elective surgery was used to identify independent risk factors, comprising the Revised Cardiac Risk Index. 10 Although major cardiac complications were rare (2%), six independent risk factors were identified ( Table 2) .
The authors specifically note that ''(T)he Index is of uncertain generalizability in lower-risk populations, such as patients who undergo minor proceduresy.'' However, data specifically examining that population is lacking, therefore this risk index is widely used.
Although risk indices can be quite useful, Reilly et al.
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used a simple-and practical-screening tool to predict perioperative risk, namely, self-reported exercise tolerance. Poor exercise tolerance, such as the inability to walk three blocks or climb two flights of stairs (o 4 metabolic equivalents, or METS), is an independent predictor of serious perioperative complications (odds ratio ¼ 1.94, 95% confidence interval, 1.19-3.17). Moreover, the likelihood of serious complications is inversely related to the number of blocks walked or flights of stairs climbed.
A decade later, in a single-center observational study, Kheterpal et al. 12 used National Surgical Quality Improvement Program data to identify preoperative and intraoperative predictors of adverse cardiac events. Their findings are consistent with findings from a decade earlier, with some modifications. Independent predictors are presented in Table 3 .
All of the aforementioned predictors except for two (emergency surgery and administration of Z1 unit of packed red blood cells) are commonly encountered in the ambulatory setting. On a related note, a supporting study by Correll et al. 13 found that age above 65 years was an independent predictor of preoperative electrocardiographic abnormalities.
The findings from the aforementioned studies and many, many others led to the most recent (2007) American Heart Association/American College of Cardiology (AHA/ACC) guidelines on perioperative evaluation for patients having noncardiac surgery.
14 These guidelines were updated in 2009 with respect to perioperative b-blockade. There are some key points in these guidelines as they relate to ambulatory surgery. First, ambulatory surgery is considered as one entity and all ambulatory procedures are considered low risk with reported cardiac mortality o 1%. Second, in the absence of ''active cardiac conditions,'' ''interventions based on cardiovascular (CV) testing in stable patients would rarely result in a change in management and it would be appropriate to proceed with the planned surgery.'' In other words, in the absence of active cardiac conditions (unstable coronary syndromes, decompensated heart failure, significant arrhythmias, and severe valvular disease), additional interventions would rarely alter perioperative risk for low-risk procedures. However, although additional testing may not be warranted (because it would rarely lead to a meaningful intervention), a complete and thorough history and physical examination, which can probe the presence or absence of active cardiac conditions, is essential.
Although additional testing may not be warranted (because it would rarely lead to a meaningful intervention), a complete and thorough history and physical examination, which can probe the presence or absence of active cardiac conditions, is essential.
PREVIOUS CORONARY INTERVENTIONS: STENTS AND CARDIAC RHYTHM DEVICES

Stents
Approximately two million patients per year in Western countries have cardiac stents placed, and 90% of those stents are drug eluting and require long-term antiplatelet therapy. Approximately 5% of stented patients will present for noncardiac surgery within the first year of stent placement. 15, 16 The implications of cardiac stents and antiplatelet therapy on preoperative assessment requires a clinical understanding of the associated risks and well-defined preoperative policies to guide patient selection and evaluation.
With any coronary stent there are risks, especially during the period of reendothelialization. Until reendothelialization is complete, patients need to remain on dual antiplatelet therapy (ie, aspirin and clopidigrel) (see Supplemental Digital Content 3, http://links.lww.com/ASA/A55). Bare metal stents (BMS) are layered with endothelial cells after approximately four to six weeks; however, there is a risk that these stents are vulnerable to restenosis over time, hence the development of drug-eluting stents (DES). DES are coated with agents that impair cellular proliferation. This can prevent restenosis but also results in a longer time to stent reendothelialization. During this period, patients must remain on dual antiplatelet therapy. Premature discontinuation of dual antiplatelet therapy, especially in the perioperative period, can be catastrophic due to stent thrombosis. [17] [18] [19] [20] [21] [22] If noncardiac surgery is performed immediately after stent placement and without antiplatelet therapy, there is a 30% risk of perioperative myocardial infarction and 20% to 40% of those are fatal. The risk of myocardial infarction and death is 5 to 10 times higher than waiting the appropriate amount of time. 
BMS implantation).''
Practice guidelines are unequivocal in stating that elective surgery be postponed until patients have completed an appropriate course of antiplatelet therapy. 14, 18, 22 The duration of antiplatelet therapy is currently estimated to be a minimum of four weeks for BMS and 12 months for DES, with aspirin being continued indefinitely. However, some patients may be more prone to thrombosis and may need to remain on dual antiplatelet therapy for longer periods. Predictors of stent thrombosis are: bifurcated lesions, long stents, diabetes, renal failure, and low ejection fractions. However, until more data are available, the practice guidelines are unequivocal. The ACC/AHA 2007 Perioperative Guidelines state: ''Elective procedures for which there is significant risk of perioperative or postoperative bleeding should be deferred until patients have completed an appropriate course of thienopyridine therapy (12 months after DES implantation if they are not at high risk of bleeding and a minimum of one month for BMS implantation).'' 14 Similarly, the ASA Practice Alert issued in 2009 affirms the position of the ACC/AHA Perioperative Guidelines. 22 Because ambulatory surgery procedures are usually elective, patients need to defer surgery until four to six weeks after placement of a BMS and one year after DES. Aspirin should be continued in the perioperative period if at all possible. To avoid confusion and compromised patient care, it is extremely useful for surgery centers to have policies that reflect these guidelines.
Cardiac Rhythm Devices
The perioperative assessment and management of the adult surgical outpatient with a CRD, either a pacemaker, an implantable defibrillator, or both, is commonplace in 2011. This poses clinical and administrative challenges. [23] [24] [25] Indeed, perioperative management of these devices is the topic of an ASA Practice Advisory. 25 The indications for the CRD should be fully appreciated, as this often reflects significant underlying cardiac disease. 23 Permanent pacemakers are indicated for symptomatic third-degree heart block, type II second-degree heart block, and sinus node dysfunction, recurrent neurally mediated syncope, and some forms of cardiomyopathy. For example, biventricular pacemakers are considered in patients with significant heart failure (ejection fraction o 35%) despite medical therapy. Implantable defibrillators are indicated in patients who have had a cardiac arrest that is not due to a temporary condition. This includes a wide array of problems including ischemia, long QT syndrome, hypertrophic cardiomyopathy, or familial cardiomyopathy. Thus the first question to be asked is, ''Why was the device placed?'' The second question is, ''Are the patient (and procedure) appropriate for outpatient surgery given the status of the cardiac disease?' ' If the patient and procedure are appropriate for the facility, then basic information about the devices should be obtained during a preoperative visit or telephone call. This should be done well in advance of surgery so that there is time to (1) decide if device interrogation or reprogramming by appropriate personnel will be necessary and (2) have enough time to coordinate personnel for preoperative and postoperative care. Information that should be obtained preoperatively is presented in Table 4 (ASA Practice Advisory).
Appropriate arrangements need to be made preoperatively so that the device can be reprogrammed (if necessary) in advance of the procedure and immediately after the procedure, without unduly inconveniencing patients or providers. If the device required reprogramming by the cardiology service/manufacturer's representative preoperatively, then original settings will need to be restored postoperatively and before discharge from the postanesthesia care unit. Until those settings are restored, patients need to have cardiac monitoring with the capability to defibrillate immediately (ie, defibrillator pads in place).
OBESITY
Approximately 34% of the adult United States population is obese and approximately 67% are overweight and obese (http://www.cdc.gov/nchs/fastats/overwt.htm, accessed May 2010). Obesity poses considerable perioperative challenges, and this is especially true in the outpatient setting where patients are expected to be discharged within a few hours after surgery. Associated comorbidities such as OSA and pulmonary dysfunction impact postoperative recovery/discharge and hence the patient selection process. A thorough understanding of the common obesity-associated comorbidities is useful to help formulate not only ambulatory anesthetic management but also patient selection criteria.
There is a direct and independent relationship between obesity and hypertension. [26] [27] [28] Furthermore, obese patients without documented hypertension are prone to occult diastolic dysfunction, probably secondary to increased circulating blood volume and chronic left ventricular wall stress. 29 Systolic dysfunction associated with obesity is a later development, and is most often seen among obese patients with body mass index (BMI) 4 40 kg/m 2 for more than 10 years. 30 Cardiac function can be difficult to assess preoperatively due to diminished functional capacity. Consequently, noninvasive testing with appropriate modalities (such as stress echocardiography) may be required if patients have multiple risk factors or have limited functional capacity. 31, 32 Reconciling the AHA/ACC cardiac evaluation and care algorithm for noncardiac surgery in obese patients having ambulatory surgery requires clinical judgment. Indeed, this issue was highlighted in the recent advisory from the AHA regarding the cardiac evaluation of severely obese patients: ''(T)hese categorizations (low, intermediate, and vascular surgery) are used in the decision algorithm for further testing but it is unknown if obesity influences these categorizations.'' 33 Consequently, this AHA advisory recommends a preoperative ECG in severely obese patients (BMI 4 40 kg/m 2 ) with one risk factor for heart disease. If there are signs of CV disease (eg, coronary artery disease, right ventricular hypertrophy consistent with pulmonary hypertension), additional workup based on functional capacity is pursued-if it will change management.
Obesity and OSA are associated with pulmonary hypertension, which poses considerable perioperative risk. However, diagnostic criteria (such as signs of right heart failure) in the absence of an echocardiogram are vague, especially in the morbidly obese. The associated postoperative mortality in patients with pulmonary hypertension across several different inpatient procedures is estimated to be 7% to 10%. 34, 35 Because of several factors, including the need for invasive intraoperative and postoperative monitoring, these patients may not be candidates for the vast majority of ambulatory procedures and need to be carefully evaluated on a case by case basis.
Obstructive Sleep Apnea
The prevalence of OSA in obese patients presenting for bariatric surgery is 71% to 77%, depending on BMI. 36 OSA is usually not a solitary diagnosis in an obese patient; associated comorbidities include hypertension and increased risk of CV disease (including stroke and sudden death). [37] [38] [39] Sudden cardiac death in (nonsurgical) obese patients is associated with a nocturnal pattern, which is distinctly different than in other populations. A review of polysomnograms and death certificates from 112 persons who experienced sudden cardiac death demonstrated that those with OSA had a peak in sudden death from cardiac causes during sleeping hours (midnight to 6 AM). In contrast, the peak incidence of sudden death occurred after 6 AM in those without OSA. 40 In the perioperative setting, patients with OSA have an increased incidence of postoperative complications. Hwang et al. 41 measured home nocturnal desaturations preoperatively in 172 patients. Patients with 5 or more desaturations/hour had a significantly higher rate of postoperative complications (15%) versus those with less than 5 events/hour (3%). Complications were primarily respiratory. Chung et al. 42 evaluated 177 patients deemed at risk for OSA by various screening tools and then performed polysomnography. Those with an apnea-hypopnea index (AHI) above 5 as confirmed by polysomnography had a postoperative complication rate that was more than double those with AHI of 5 or less (27% vs. 12%).
Discerning who actually has OSA is challenging, as the diagnostic ''gold standard'' is polysomnography, which many patients do not obtain. Diagnosis based on screening questionnaires is unreliable. A meta-analysis of clinical screening tests for OSA illustrates that it is possible to predict severe OSA with a high degree of accuracy. However, aside from severe OSA, false-negative rates range from 14% to 38%, which will miss a significant proportion of patients. 43 Nevertheless, simple screening methods have been developed for preoperative use including the STOP-BANG questionnaire (Table 5) , which has a sensitivity from 84% (AHI 4 5) to 100% (AHI 430). Patients who answer yes to 3 or more items are considered to be at high risk for OSA. 42 Other similar validated tools incorporate upper airway anatomy to enhance predictive modeling. 44 A main concern for patients with OSA is their suitability for ambulatory surgery. Is it safe to send these patients home to an unmonitored setting after anesthesia and surgery? Data are scant since important determinants such as severity of OSA, type of anesthetic, and type of procedure have not been individually examined. Instead, we have expert opinions extrapolated from the inpatient setting and used as a guide Specifically in reference to outpatients, the ASA Guidelines recommend: ''These patients should not be discharged from the recovery area to an unmonitored setting (ie, home or unmonitored hospital bed) until they are no longer at risk for postoperative respiratory depression.'' The Guidelines also recommend observing patients while breathing room air in an unstimulated environment and note that this may require a longer ambulatory stay (ie, 3 hours longer than non-OSA counterparts and median of 7 hours after the last episode of airway obstruction or hypoxemia while breathing room air in an unstimulating environment). Practical application has been challenging because patients frequently do not have a formal preoperative diagnosis of OSA and severity is difficult to estimate. Most likely, recommendations in this arena will continue to evolve as more relevant data become available.
DIABETES
Approximately 14% of United States adults aged 20 years and above and approximately 23% of individuals older than 60 years have diabetes or impaired fasting glucose (http://www.cdc.gov, accessed May 2010). To evaluate potential end-organ damage and maintain metabolic homeostasis, these patients require a focused assessment to (1) gauge their appropriateness for an outpatient procedure, focusing on the potentially difficult airway in patients with long-standing type I diabetes and (2) guide preoperative fasting and insulin instructions.
CV disease is the major cause of morbidity and mortality among patients with diabetes, with the most common conditions being hypertension and dyslipidemias. The most recent American Diabetes Association guidelines recommend that patients with diabetes be treated to a blood pressure o 130 mmHg systolic and o 80 mmHg diastolic. Furthermore, it is recommended that all patients with diabetes have serum creatinine measured and CV risk factors such as dyslipidemia, hypertension, smoking, positive history of coronary disease, and presence of microalbuminemia or macroalbuminemia assessed annually. This is part of routine health maintenance and is independent of surgical need. Further cardiac testing-irrespective of the need for surgery-should be considered in diabetics with typical or atypical anginal symptoms or an abnormal resting ECG. 46 Patients with diabetes may be on complicated regimens to achieve glycemic goals to reduce the risk of microvascular and macrovascular complications. In addition to insulin and conventional oral hypoglycemic agents, treatment may include relatively new classes of gastrointestinal hormonesnamely incretins and amylin-which impact glucose homeostasis. 47 In adults, glycemic goals are: A1C r 7%, preprandial glucose 70 to 130 mg/dL, and peak postprandial glucose o 180 mg/dL. 46 Owing to concerns about perioperative hypoglycemia as delineated in the NICE-SUGAR study, perioperative glycemic goals as suggested by the American Diabetes Association are in the range of 120 to 180 mg/dL. 46, 48 To achieve those targets and simplify preoperative instructions, ambulatory surgery centers usually have protocols that address the type and quantity of insulin (and other hypoglycemic agents) to be administered preoperatively, recommendations for monitoring blood sugar preoperatively, and treating hypoglycemia while adhering to nil per os guidelines. A common feature in these protocols is to include a basal form of insulin on the day of surgery (usually as a fraction of the typical intermediate acting insulin or long-acting insulin) and withhold oral hypoglycemic agents and incretins. 47, 49, 50 A basic understanding of the time course of commonly used insulins is integral to developing effective preoperative instructions (Table 6 ).
SUMMARY
Outpatient evaluation is the basis for patient selection, which is fundamental for safe and efficient ambulatory anesthetic management. Models of evaluation include: assessment on the day of surgery, telephone triage, or preoperative clinic visit. Each model has its advantages, and adoption depends on the facility and patient demographics. Irrespective of the method, patients are evaluated with discharge planning in mind. Patients should be suitable for elective surgery with the expectation that they can be safely discharged home within a few hours of their procedure. Several comorbidities affect this process and require refinement of patient assessments and selection criteria. 
